Nadim Mahmud1,2, Rebecca A Hubbard3, David E Kaplan1,4, Tamar H Taddei5,6, David S Goldberg7. 1. Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 2. Leonard David Institute of Health Economics, University of Pennsylvania, Philadelphia, PA, USA. 3. Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics, Epidemiology & Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. 4. Department of Medicine, Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA. 5. Division of Digestive Diseases, Yale University School of Medicine, New Haven, CT, USA. 6. VA Connecticut Healthcare System, West Haven, CT, USA. 7. Division of Digestive Health and Liver Diseases, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA.
Abstract
BACKGROUND & AIMS: Acute on chronic liver failure (ACLF) causes high short-term mortality in patients with previously stable chronic liver disease. To date there are no models to predict which patients are likely to develop ACLF, and existing models to predict ACLF mortality are based on limited cohorts. We sought to create novel risk prediction scores using a large cohort of patients with cirrhosis. METHODS: We performed a retrospective cohort study of 74 790 patients with incident cirrhosis in the Veterans Health Administration database using randomized 70% derivation/30% validation sets. ACLF events were identified per the European ACLF criteria. Multivariable logistic regression was used to derive prediction models for developing ACLF at 3, 6 and 12 months, and ACLF mortality at 28 and 90 days. Mortality models were compared to model for end-stage liver disease (MELD), MELD-sodium and the Chronic Liver Failure Consortium (CLIF-C) ACLF score. RESULTS: Models for the developing ACLF had very good discrimination (concordance [C] statistics 0.83-0.87) at all timepoints. Models for ACLF mortality also had good discrimination at 28 and 90 days (C-statistics 0.79-0.82), and were superior to MELD, MELD-sodium and the CLIF-C ACLF score. The calibration of the novel models was excellent at all timepoints. CONCLUSION: We have obtained highly-predictive models for developing ACLF, as well as for ACLF short-term mortality in a diverse United States cohort. These may be used to identify outpatients at significant risk of ACLF, which may prompt closer follow-up or early transplant referral, and facilitate decision making for patients with diagnosed ACLF, including escalation of care, expedited transplant evaluation or palliation.
BACKGROUND & AIMS: Acute on chronic liver failure (ACLF) causes high short-term mortality in patients with previously stable chronic liver disease. To date there are no models to predict which patients are likely to develop ACLF, and existing models to predict ACLF mortality are based on limited cohorts. We sought to create novel risk prediction scores using a large cohort of patients with cirrhosis. METHODS: We performed a retrospective cohort study of 74 790 patients with incident cirrhosis in the Veterans Health Administration database using randomized 70% derivation/30% validation sets. ACLF events were identified per the European ACLF criteria. Multivariable logistic regression was used to derive prediction models for developing ACLF at 3, 6 and 12 months, and ACLF mortality at 28 and 90 days. Mortality models were compared to model for end-stage liver disease (MELD), MELD-sodium and the Chronic Liver Failure Consortium (CLIF-C) ACLF score. RESULTS: Models for the developing ACLF had very good discrimination (concordance [C] statistics 0.83-0.87) at all timepoints. Models for ACLF mortality also had good discrimination at 28 and 90 days (C-statistics 0.79-0.82), and were superior to MELD, MELD-sodium and the CLIF-C ACLF score. The calibration of the novel models was excellent at all timepoints. CONCLUSION: We have obtained highly-predictive models for developing ACLF, as well as for ACLF short-term mortality in a diverse United States cohort. These may be used to identify outpatients at significant risk of ACLF, which may prompt closer follow-up or early transplant referral, and facilitate decision making for patients with diagnosed ACLF, including escalation of care, expedited transplant evaluation or palliation.
Authors: Evangelia Christodoulou; Jie Ma; Gary S Collins; Ewout W Steyerberg; Jan Y Verbakel; Ben Van Calster Journal: J Clin Epidemiol Date: 2019-02-11 Impact factor: 6.437
Authors: Richard Moreau; Rajiv Jalan; Pere Gines; Marco Pavesi; Paolo Angeli; Juan Cordoba; Francois Durand; Thierry Gustot; Faouzi Saliba; Marco Domenicali; Alexander Gerbes; Julia Wendon; Carlo Alessandria; Wim Laleman; Stefan Zeuzem; Jonel Trebicka; Mauro Bernardi; Vicente Arroyo Journal: Gastroenterology Date: 2013-03-06 Impact factor: 22.682
Authors: David S Goldberg; Benjamin French; Kimberly A Forde; Peter W Groeneveld; Therese Bittermann; Lisa Backus; Scott D Halpern; David E Kaplan Journal: JAMA Date: 2014-03-26 Impact factor: 56.272
Authors: Ruben Hernaez; Jennifer R Kramer; Yan Liu; Aylin Tansel; Yamini Natarajan; Khozema B Hussain; Pere Ginès; Elsa Solà; Richard Moreau; Alexander Gerbes; Hashem B El-Serag; Fasiha Kanwal Journal: J Hepatol Date: 2018-12-25 Impact factor: 25.083
Authors: Karen Y Xiao; Rebecca A Hubbard; David E Kaplan; Tamar H Taddei; David S Goldberg; Nadim Mahmud Journal: Hepatol Int Date: 2020-06-09 Impact factor: 6.047
Authors: Shivani Shah; David S Goldberg; David E Kaplan; Vinay Sundaram; Tamar H Taddei; Nadim Mahmud Journal: Liver Transpl Date: 2020-10-28 Impact factor: 5.799
Authors: Nadim Mahmud; Sara Chapin; David S Goldberg; K Rajender Reddy; Tamar H Taddei; David E Kaplan Journal: J Hepatol Date: 2022-01-21 Impact factor: 30.083
Authors: Fasiha Kanwal; Thomas J Taylor; Jennifer R Kramer; Yumei Cao; Donna Smith; Allen L Gifford; Hashem B El-Serag; Aanand D Naik; Steven M Asch Journal: JAMA Netw Open Date: 2020-11-02
Authors: Nadim Mahmud; Sumeet K Asrani; David E Kaplan; Gerald O Ogola; Tamar H Taddei; Patrick S Kamath; Marina Serper Journal: Liver Transpl Date: 2020-12-09 Impact factor: 5.799